For the latest updates on Gilead’s ongoing response to COVID-19, please click here.
LEARN ABOUT OUR RECENT APPROVAL
View our media materials:
Non-Hodgkin Lymphoma
Understanding Chimeric Antigen Receptor (CAR) T Cell Technology
